Join Growin Stock Community!

Xoma corporationXOMAP.US Overview

US StockHealthcare
(No presentation for XOMAP)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

XOMAP AI Insights

XOMAP Overall Performance

XOMAP AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

XOMAP Recent Performance

0.12%

Xoma corporation

0.05%

Avg of Sector

-0.31%

S&P500

XOMAP PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

XOMAP Key Information

XOMAP Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

XOMAP Profile

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Price of XOMAP

XOMAP FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

XOMAP Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.81
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
57.35
METRIC
VALUE
vs. INDUSTRY
Gross Margin
93.57%
Net Margin
46.15%
Revenue Growth (YoY)
118.02%
Profit Growth (YoY)
118.02%
3-Year Revenue Growth
174.72%
3-Year Profit Growth
175.77%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.81
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
57.35
Gross Margin
93.57%
Net Margin
46.15%
Revenue Growth (YoY)
118.02%
Profit Growth (YoY)
118.02%
3-Year Revenue Growth
174.72%
3-Year Profit Growth
175.77%
  • When is XOMAP's latest earnings report released?

    The most recent financial report for Xoma corporation (XOMAP) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating XOMAP's short-term business performance and financial health. For the latest updates on XOMAP's earnings releases, visit this page regularly.

  • Where does XOMAP fall in the P/E River chart?

    According to historical valuation range analysis, Xoma corporation (XOMAP)'s current price-to-earnings (P/E) ratio is 5.68, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of XOMAP?

    According to the latest financial report, Xoma corporation (XOMAP) reported an Operating Profit of -1.33M with an Operating Margin of -14.22% this period, representing a growth of 91.5% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is XOMAP's revenue growth?

    In the latest financial report, Xoma corporation (XOMAP) announced revenue of 9.35M, with a Year-Over-Year growth rate of 29.93%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does XOMAP have?

    As of the end of the reporting period, Xoma corporation (XOMAP) had total debt of 131.91M, with a debt ratio of 0.5. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does XOMAP have?

    At the end of the period, Xoma corporation (XOMAP) held Total Cash and Cash Equivalents of 90.48M, accounting for 0.34 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does XOMAP go with three margins increasing?

    In the latest report, Xoma corporation (XOMAP) did not achieve the “three margins increasing” benchmark, with a gross margin of 90.61%%, operating margin of -14.22%%, and net margin of 151.31%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess XOMAP's profit trajectory and future growth potential.

  • Is XOMAP's EPS continuing to grow?

    According to the past four quarterly reports, Xoma corporation (XOMAP)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.74. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of XOMAP?

    Xoma corporation (XOMAP)'s Free Cash Flow (FCF) for the period is -296K, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 96.6% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of XOMAP?

    The latest valuation data shows Xoma corporation (XOMAP) has a Price-To-Earnings (PE) ratio of 5.68 and a Price/Earnings-To-Growth (PEG) ratio of 0.09. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.